Financial statements Santepharm

Balance sheet of Santepharm

Company age:
Age:
9 y. 2 m. 21 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of SANTEPHARM

Year
2018
2019
2020
2021
2022
Total assets 553 242,31 5 697 677,56 8 573 993,83 1 866 810,08 40 058,66
A. Fixed assets 66 453,70 0,00 0,00 0,00 0,00
B. Current assets 486 788,61 5 697 677,56 8 573 993,83 1 866 810,08 40 058,66
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 553 242,31 5 697 677,56 8 573 993,83 1 866 810,08 40 058,66
A. Equity 547 155,11 5 690 662,82 8 573 993,83 1 866 810,08 35 430,88
B. Liabilities and provisions for liabilities 6 087,20 7 014,74 0,00 0,00 4 627,78
I. Long-term liabilities - - - - -
II. Short-term liabilities - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.